AAGP eNews
Oct. 7, 2014

Excessive worry in middle-aged women linked to higher Alzheimer's risk
The Washington Post
Here's something to worry about: A recent study suggests that middle-age women whose personalities tend toward the neurotic run a higher risk of developing Alzheimer's disease later in life. The study by researchers at the University of Gothenburg in Sweden followed a group of women in their 40s, whose disposition made them prone to anxiety, moodiness and psychological distress, to see how many developed dementia over the next 38 years.More

UCLA researcher: Therapeutic program reverses Alzheimer's memory loss
McKnight's Long Term Care News
An intensive therapy regimen involving medication, diet and behavioral changes successfully reversed Alzheimer's-related memory loss in a first-of-its-kind trial, according to findings out of the University of California, Los Angeles. The small study involved 10 people experiencing memory loss from Alzheimer's and other conditions. Of these, nine showed "subjective or objective" memory improvement within three to six months of starting the program, the UCLA investigator determined. Of six who had left their jobs or were struggling, all were able to return to work or continue working. The one patient who did not improve had late-stage Alzheimer's.More

What I learned about love as a caregiver to an Alzheimer's patient
The Huffington Post
"For seven years, I'd help my friend Ed get dressed and eat breakfast before I went off to work. But he'd soon call, desperately needing my help for some or other perceived crisis. I'd leave my job then return later. By afternoon, he usually had some other emergency, and I'd have to go out again. I'd return to work frazzled and try to finish some project with a looming deadline. It was a miracle I didn't lose my job. I'd fall into bed at night, exhausted, only to repeat my duties the next day," writes Marie Marley, an award-winning author. More

Most dangerous aggregates in Alzheimer's identified
Genetic Engineering & Biotechnology News
Beta amyloid, the peptide long associated with Alzheimer's disease, embodies a diabolical version of the Goldilocks principle. For beta amyloid, "just right," when it comes to killing neurons, means forming aggregates of intermediate size—specifically, aggregates of 20 to 100 units. Neither smaller aggregates nor amyloid fibrils, which can contain up to 3,000 peptide units, are as toxic. This finding, from scientists based at the Institute for Research in Biomedicine (IRB Barcelona), squarely faces one of the key uncertainties in Alzheimer's research, namely, the lack of unequivocal proof that beta amyloid causes the onset and development of the disease. More

5 states expected to see the biggest increase in Alzheimer's disease
Motley Fool
Cancer and heart disease may be far more prevalent killers, but Alzheimer's disease is certainly no ailment to overlook, considering that it's the eighth leading cause of death in the United States. According to statistics from the Alzheimer's Association, or AA, one in nine Americans age 65 or older has Alzheimer's. While an Alzheimer's diagnosis might seem like it would be at random on a state-by-state basis, there are clearly states whose rate of diagnosis is expected to soar during the coming decade. Based on estimates from the AA in its 2014 Alzheimer's Disease Facts and Figures report, here are five states that are projected to see their Alzheimer's diagnoses soar by a minimum of 54.5 percent between 2014 and 2025. More

Promising drug candidate for Alzheimer's found in turmeric compound
Medical News Today
The bright yellow spice sitting in your kitchen — that you sometimes use to make curry powder — has a compound that could be used as a drug candidate for treating neurological disorders. Researchers from the Institute of Neuroscience and Medicine in Jülich, Germany, say a turmeric compound promotes stem cell proliferation and differentiation in the brain, giving hope for patients who suffer from stroke and Alzheimer's disease. More

Excessive worry in middle-aged women linked to higher Alzheimer's risk
The Washington Post
Here's something to worry about: A recent study suggests that middle-age women whose personalities tend toward the neurotic run a higher risk of developing Alzheimer's disease later in life.More

Drugs for anxiety, sleep linked to Alzheimer's disease
By Denise A. Valenti
Drugs used to modify behavior in young or middle-aged adults may have serious consequences in later life. Recent research has demonstrated that extended use of benzodiazepine drugs increase the risk of developing Alzheimer's disease.More

New CME credit opportunity for PBS film Genius of Marian
The Genius of Marian is an intimate and courageous portrait of filmmaker Banker White's 61-year-old mother, who is struggling with early-onset Alzheimer's disease.More

Early memory lapses may be sign of dementia
A new study in the American Academy of Neurology suggests that people who feel they are forgetting more things may need to be concerned, even if bigger issues aren't yet showing up on cognitive tests. Participants who reported memory problems at the beginning of the study were more likely to have dementia down the road than those who did not.More

UMMC gets $1 million for Alzheimer's research
The Associated Press via The Washington Times
A Jackson businessman has donated $1 million to the University of Mississippi Medical Center to study Alzheimer's disease. The donation from John Palmer puts fundraising for UMMC's Memory Impairment and Neurodegenerative Dementia Research Center over the $10 million goal that was set when the center opened.More